Revospirone
Revospirone (BAY Vq 7813) is a partial agonist of the 5-HT1A receptor with a Ki of 2 nmol/L. Revospirone inhibits adenylate cyclase activity with an IC50 of 124 nmol/L[1].
Product Specifications
CAS Number
95847-87-3
Product Name Alternative
BAY Vq 7813
UNSPSC
12352005
Target
5-HT Receptor; Adenylate Cyclase
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/revospirone.html
Solubility
10 mM in DMSO
Smiles
O=C1C2=C(S(=O)(N1CCCN3CCN(CC3)C4=NC=CC=N4)=O)C=CC=C2
Molecular Formula
C18H21N5O3S
Molecular Weight
387.46
References & Citations
[1]Löscher, W et al. The behavioural responses to 8-OH-DPAT, ipsapirone and the novel 5-HT1A receptor agonist Bay Vq 7813 in the pig. Naunyn-Schmiedeberg's archives of pharmacology vol. 342,3 (1990) : 271-7.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
5-HT1 Receptor
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
